Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Adds Cardiovascular Drug Discovery Product

NEW YORK, May 15 – Gene Logic announced on Tuesday the launch of its Cardiovascular DataSuite as an extension product of its GeneExpress Suite. 

The cardiovascular package will include access to GeneExpress’ data management and analysis software platform. Subscribers to the new product will receive regular updates to the cardiovascular content and bioinformatics tools, according to the company.

The Cardiovascular DataSuite, aimed at pharmaceutical and biotechnology drug discovery and development customers, includes normal and diseased human cardiac and vascular tissues from a broad selection of individuals, races, medication regimens, lifestyles, and disease stages, the company reports.

The product also includes disease animal model systems related to cardiovascular indications to allow non-human and human disease model comparison. According to the Gaithersburg, Maryland-based, company, the new product will assist researchers in identifying potential new drug targets and surrogate markers for diagnosis, progression, and prognosis of cardiovascular diseases. 

“The Cardiovascular DataSuite is an extension of our mission to provide value-added gene expression information solutions that directly address the critical research and development needs of the pharmaceutical and biotechnology communities,” Gene Logic senior vice president for marketing and sales David S. Murray said in a statement.


The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.